Co-Authors
This is a "connection" page, showing publications co-authored by Carolina Scagnolari and Guido Antonelli.
Connection Strength
8.077
-
No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy. J Cyst Fibros. 2020 09; 19(5):837-838.
Score: 0.889
-
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients. J Clin Virol. 2020 07; 128:104450.
Score: 0.883
-
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome. Cytokine Growth Factor Rev. 2018 04; 40:19-31.
Score: 0.759
-
Antiviral Activity of the Combination of Interferon and Ribavirin Against Chikungunya Virus: Are the Results Conclusive? J Infect Dis. 2017 02 01; 215(3):492-493.
Score: 0.703
-
Consolidation of molecular testing in clinical virology. Expert Rev Anti Infect Ther. 2017 04; 15(4):387-400.
Score: 0.697
-
Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis. Virus Res. 2012 May; 165(2):236-40.
Score: 0.499
-
Severe acute respiratory syndrome coronavirus elicits a weak interferon response compared to traditional interferon-inducing viruses. Intervirology. 2008; 51(4):217-23.
Score: 0.393
-
The synergistic interaction of interferon types I and II leads to marked reduction in severe acute respiratory syndrome-associated coronavirus replication and increase in the expression of mRNAs for interferon-induced proteins. Intervirology. 2007; 50(2):156-60.
Score: 0.349
-
Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antivir Ther. 2004 Dec; 9(6):1003-11.
Score: 0.302
-
ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? Cytokine. 2021 04; 140:155430.
Score: 0.231
-
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19). Virus Res. 2021 04 02; 295:198283.
Score: 0.231
-
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients. Microorganisms. 2021 Jan 03; 9(1).
Score: 0.230
-
Increased expression of IL-32 correlates with IFN-?, Th1 and Tc1 in virologically suppressed HIV-1-infected patients. Cytokine. 2019 08; 120:273-281.
Score: 0.204
-
Increased IL-17 and/or IFN-? producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women. AIDS. 2019 03 15; 33(4):627-636.
Score: 0.203
-
Respiratory syncytial virus. Minerva Pediatr. 2018 Dec; 70(6):553-565.
Score: 0.198
-
Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation. J Immunol Res. 2018; 2018:1738676.
Score: 0.195
-
Interferon lambda receptor 1 (IFNL1R) transcript is highly expressed in rhinovirus bronchiolitis and correlates with disease severity. J Clin Virol. 2018 05; 102:101-109.
Score: 0.190
-
Rhinovirus species/genotypes and interferon-?: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma? Eur Respir J. 2017 03; 49(3).
Score: 0.178
-
Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy. J Med Virol. 2007 Apr; 79(4):463-8.
Score: 0.089
-
Treatment of SARS with human interferons. Lancet. 2003 Oct 04; 362(9390):1158; author reply 1158-9.
Score: 0.070
-
KI and WU Polyomavirus in Respiratory Samples of SARS-CoV-2 Infected Patients. Microorganisms. 2021 Jun 09; 9(6).
Score: 0.059
-
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro. Pharmacol Res. 2021 01; 163:105255.
Score: 0.057
-
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report. Medicine (Baltimore). 2020 Sep 04; 99(36):e21803.
Score: 0.056
-
Interferon-ß-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection. J Infect Dis. 2020 Aug 04; 222(5):722-725.
Score: 0.056
-
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med (Lausanne). 2020; 7:389.
Score: 0.056
-
How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis. J Infect Dis. 2019 01 29; 219(4):526-534.
Score: 0.050
-
Interferon lambda4 polymorphism is not associated with human papillomavirus infection outcome. Virus Genes. 2018 Apr; 54(2):319-322.
Score: 0.047
-
Acute bronchiolitis: Influence of viral co-infection in infants hospitalized over 12 consecutive epidemic seasons. J Med Virol. 2018 04; 90(4):631-638.
Score: 0.047
-
Respiratory syncytial virus bronchiolitis, weather conditions and air pollution in an Italian urban area: An observational study. Environ Res. 2017 10; 158:188-193.
Score: 0.045
-
Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients. Immun Inflamm Dis. 2017 09; 5(3):244-260.
Score: 0.045
-
Bronchiolitis: Analysis of 10 consecutive epidemic seasons. Pediatr Pulmonol. 2016 12; 51(12):1330-1335.
Score: 0.042
-
Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child. 2010 Jan; 95(1):35-41.
Score: 0.026